Richard Messmann
Chief Medical Officer Convergent Therapeutics, Inc
Seminars
- Exploring chemical structures, medicinal chemistry and delivery mechanisms
- Understanding key steps for successful translation and early clinical design
- Assembling the clinical workforce for the path to commercialization
Join our open session to ask your burning questions to the industry leaders ahead of the main conference to equip your team with expert knowledge ahead of the main conference.
Join this session to ask exactly what you want to know on topics like:
- R&D and Preclinical: novel target choices, targeting molecules, linkers, chelators, preclinical dosimetry and more
- CMC and Regulatory: isotope properties, differences in supply chain, logistics networks, CMC innovations, regulatory considerations and more
- Clinical Development: clinical trial design, working with sites, working with clinical stakeholders, patient centric approaches and more
• Industry-clinic collaborations
• Forward planning to avoid delays
• Accelerating development among nuclear medicine teams
• Using real-world clinical outcomes to provide insights into patient populations, treatment efficacy and long-term safety
• Enhancing trial design through optimal patient selection, dosing strategies and endpoints
• Guiding potential personalized treatment strategies
- Delving into the radiopharma landscape and technical development pathways
- Sharing experiences
